Gene therapy increases survival for end-stage head and neck cancer
... at www.introgen.com . Better Quality of Life Patients treated with advexin experienced far fewer harmful side effects such as pneumonia than those who... other tumor-suppressing genes systemically - through intravenous delivery. advexin has to be injected straight into the tumor, but that's not workable for man...Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Introgen Therapeutics, Inc. (NASDAQ:INGN) reported updated ADVEXIN(R) biomarker data over the weekend in Los Angeles, California at the Annual Meeting of the American Association for Cancer Research. Abnormality of the p53 tumor suppressor is one of the...Introgen's Advexin Demonstrates Clinical Benefit in Inherited Cancer
Case History Highlighted in AACR Cancer Journal AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today the publication of data describing the dramatic clinical benefit of its lead product Advexin in a patient with a rare inherited form of cancer k...Abnormal overexpression of p53 is a predictive molecular biomarker
...otein were significantly more likely to respond to advexin therapy than those whose tumor showed little p53 protein. advexin is a gene based drug, injected directly into tumor...ormal p53 levels in cells are typically low. advexin is farthest along in federal Food and Drug Adminis...